Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jean-Michel Azorin, Nicolas Simon, Marc Adida & Raoul Belzeaux. (2016) Pharmacological treatment of schizophrenia with comorbid substance use disorder. Expert Opinion on Pharmacotherapy 17:2, pages 231-253.
Read now
Read now
Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller, WFSBP Task Force on Treatment Guidelines for Schizophrenia, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Hans-Jürgen Möller & WFSBP Task Force on Treatment Guidelines for Schizophrenia. (2005) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia. The World Journal of Biological Psychiatry 6:3, pages 132-191.
Read now
Read now
Kenneth Tardiff, Peter M. Marzuk, Andrew C. Leon, Laura Portera, Nancy Hartwell, Charles S. Hirsch & Marina Stajic. (1996) Accidental Fatal Drug Overdoses in New York City: 1990–1992. The American Journal of Drug and Alcohol Abuse 22:2, pages 135-146.
Read now
Read now
Articles from other publishers (62)
Maxwell Miller, Alisa Zezetko & Ritvij Satodiya. (2023) Development of Atypical Neuroleptic Malignant Syndrome After Treatment of Cocaine Intoxication: A Case Report and Literature Review. Cureus.
Crossref
Crossref
Ashley J. Choe, Ross Ellison, Sunil R. Ramaswamy, Rachel F. Schult, Roy Gerona & Nicholas Nacca. (2023) Profound Hyperthermia Associated With Fentanyl and Cocaine Use With Suspected Synephrine Adulteration. The Journal of Emergency Medicine 64:2, pages 259-262.
Crossref
Crossref
Rita Roque Bravo, Ana Carolina Faria, Andreia Machado Brito-da-Costa, Helena Carmo, Přemysl Mladěnka, Diana Dias da Silva & Fernando Remião. (2022) Cocaine: An Updated Overview on Chemistry, Detection, Biokinetics, and Pharmacotoxicological Aspects including Abuse Pattern. Toxins 14:4, pages 278.
Crossref
Crossref
A. F. A. Schellekens, M. Belgers, W. van den Brink, M. S. van Noorden, A. Batalla, J. Veraart & J. J. Luykx. 2022. Acute psychiatrie. Acute psychiatrie
237
245
.
Tsuyoshi Okada, Katsutoshi Shioda, Akiko Makiguchi & Shiro Suda. (2020) Risperidone and 5-HT2A Receptor Antagonists Attenuate and Reverse Cocaine-Induced Hyperthermia in Rats. International Journal of Neuropsychopharmacology 23:12, pages 811-820.
Crossref
Crossref
Brigitte HurtubiseAdam MacLellan. (2019) Clinical Reasoning: A case of acute encephalopathy and rigidity in a 30-year-old man. Neurology 93:17, pages 759-763.
Crossref
Crossref
Wolfgang Gaebel, Alkomiet Hasan & Peter Falkai. 2019. S3-Leitlinie Schizophrenie. S3-Leitlinie Schizophrenie
181
254
.
Ofer Havakuk, Shereif H. Rezkalla & Robert A. Kloner. (2017) The Cardiovascular Effects of Cocaine. Journal of the American College of Cardiology 70:1, pages 101-113.
Crossref
Crossref
Deborah C. Mash. (2016) Excited Delirium and Sudden Death: A Syndromal Disorder at the Extreme End of the Neuropsychiatric Continuum. Frontiers in Physiology 7.
Crossref
Crossref
Kevin A. Sevarino & Bryan C. Shelby. 2015. Psychiatry. Psychiatry
1561
1614
.
B. Daniel Seijas. (2014) Adicciones y depresión en la salud del hombre. Revista Médica Clínica Las Condes 25:1, pages 79-98.
Crossref
Crossref
Jean Lud Cadet, Veronica Bisagno & Christopher Mark Milroy. (2013) Neuropathology of substance use disorders. Acta Neuropathologica 127:1, pages 91-107.
Crossref
Crossref
Daniel E. Huddleston & Stewart A. Factor. 2013. Movement Disorder Emergencies. Movement Disorder Emergencies
29
41
.
Thomas M. Penders, Richard E. Gestring & Dmitry A. Vilensky. (2012) Excited delirium following use of synthetic cathinones (bath salts). General Hospital Psychiatry 34:6, pages 647-650.
Crossref
Crossref
Jay Menaker, David A. Farcy, Sharon A. Boswell, Deborah M. Stein, Richard P. Dutton, John R. Hess & Thomas M. Scalea. (2011) Cocaine-Induced Agitated Delirium with Associated Hyperthermia: A Case Report. The Journal of Emergency Medicine 41:3, pages e49-e53.
Crossref
Crossref
Jared Strote, Mimi Walsh, Matthew Angelidis, Amaya Basta & H. Range Hutson. (2010) Conducted Electrical Weapon Use by Law Enforcement: An Evaluation of Safety and Injury. Journal of Trauma: Injury, Infection & Critical Care 68:5, pages 1239-1246.
Crossref
Crossref
A. Lee Lewis & David A. Kahn. (2009) Malignant Catatonia in a Patient with Bipolar Disorder, B12 Deficiency, and Neuroleptic Malignant Syndrome. Journal of Psychiatric Practice 15:5, pages 415-422.
Crossref
Crossref
Deborah C. Mash, Linda Duque, John Pablo, Yujing Qin, Nikhil Adi, W. Lee Hearn, Bruce A. Hyma, Steven B. Karch, Henrik Druid & Charles V. Wetli. (2009) Brain biomarkers for identifying excited delirium as a cause of sudden death. Forensic Science International 190:1-3, pages e13-e19.
Crossref
Crossref
Hari S. Sharma, Dafin Muresanu, Aruna Sharma & Ranjana Patnaik. 2009. New Concepts of Psychostimulant Induced Neurotoxicity. New Concepts of Psychostimulant Induced Neurotoxicity
297
334
.
Deborah C. Mash. 2009. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law
365
377
.
T. Wobrock & M. Soyka. (2008) Pharmacotherapy of schizophrenia with comorbid substance use disorder — Reviewing the evidence and clinical recommendations. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:6, pages 1375-1385.
Crossref
Crossref
Chadwick W. Christine & Michael J. Aminoff. 2008. Neurology and General Medicine. Neurology and General Medicine
1095
1121
.
T. Wobrock, R. D’Amelio & P. Falkai. (2007) Pharmakotherapie bei Schizophrenie und komorbider SubstanzstörungPharmacotherapy of schizophrenia and comorbid substance use disorder. Der Nervenarzt 79:1, pages 17-35.
Crossref
Crossref
Michael Bell. 2007. Pathology, Toxicogenetics, and Criminalistics of Drug Abuse. Pathology, Toxicogenetics, and Criminalistics of Drug Abuse
137
151
.
Neal Benowitz, Brett Roth & Kent Olson. 2007. Addiction and the Medical Complications of Drug Abuse. Addiction and the Medical Complications of Drug Abuse
81
147
.
Deborah Mash. 2007. Neurochemistry of Abused Drugs. Neurochemistry of Abused Drugs
109
117
.
Neal L. Benowitz. 2007. Ciba Foundation Symposium 166 ‐ Cocaine: Scientific and Social Dimensions. Ciba Foundation Symposium 166 ‐ Cocaine: Scientific and Social Dimensions
125
148
.
Neal Benowitz. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
597
694
.
Julie Staley & Kelly Cosgrove. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
429
558
.
Charles Wetli. 2006. Drug Abuse Handbook, Second Edition. Drug Abuse Handbook, Second Edition
71
145
.
Darrell L. Ross. 2006. Sudden Deaths in Custody. Sudden Deaths in Custody
139
165
.
Suzanne R. White. (2016) Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome. Journal of Pharmacy Practice 18:3, pages 175-187.
Crossref
Crossref
C.V. Wetli. 2005. Encyclopedia of Forensic and Legal Medicine. Encyclopedia of Forensic and Legal Medicine
276
281
.
Stewart A. Factor. 2005. Drug Induced Movement Disorders. Drug Induced Movement Disorders
174
212
.
Jambur Ananth, Kamala Aduri, Sharath Parameswaran & Sarath Gunatilake. (2014) Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment. Acta Neuropsychiatrica 16:4, pages 219-228.
Crossref
Crossref
Max Fink & Michael Alan Taylor. 2009. Catatonia. Catatonia.
W. J. WeinerA. RabinsteinB. LevinC. WeinerL. M. Shulman. (2001) Cocaine-induced persistent dyskinesias. Neurology 56:7, pages 964-965.
Crossref
Crossref
Ronald L. O'Halloran & Janice G. Frank. (2000) Asphyxial Death During Prone Restraint Revisited. The American Journal of Forensic Medicine and Pathology 21:1, pages 39-52.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 2000. Drug and Alcohol Abuse. Drug and Alcohol Abuse
119
146
.
B. J. Stanford & S. C. Stanford. (2016) Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?. Journal of Psychopharmacology 13:3, pages 313-317.
Crossref
Crossref
James L. York & Kim Mackinnon. (1999) Acute and Chronic Alcohol–Cocaine Interactions in Rats. Alcohol 17:1, pages 13-18.
Crossref
Crossref
Carey A. Cullinane, Christopher Brumfield, Lewis M. Flint & John J. Ferrara. (1998) Neuroleptic Malignant Syndrome Associated with Multiple Joint Dislocations in a Trauma Patient. The Journal of Trauma: Injury, Infection, and Critical Care 45:1, pages 168-171.
Crossref
Crossref
Donald T. Reay. (1998) Death in Custody. Clinics in Laboratory Medicine 18:1, pages 1-22.
Crossref
Crossref
A. James RuttenberJanet Lawler-HeavnerMing YinCharles V. WetliW. Lee HearnDeborah C. Mash. (1997) Fatal Excited Delirium Following Cocaine Use: Epidemiologic Findings Provide New Evidence for Mechanisms of Cocaine Toxicity. Journal of Forensic Sciences 42:1, pages 14064J.
Crossref
Crossref
EMMANUEL S. ONAIVI, CASSANDRA BISHOP-ROBINSON, EVANGELINE D. MOTLEY, AMITABHA CHAKRABARTI & SANIKA S. CHIRWA. (1996) Neurobiological Actions of Cocaine in the Hippocampus. Annals of the New York Academy of Sciences 801:1 Cellular and, pages 76-94.
Crossref
Crossref
Charles V Wetli, Deborah Mash & Steven B Karch. (1996) Cocaine-associated agitated delirium and the neuroleptic malignant syndrome. The American Journal of Emergency Medicine 14:4, pages 425-428.
Crossref
Crossref
Christopher C. Young & Brian S. Kaufman. (1995) Neuroleptic malignant syndrome postoperative onset due to levodopa withdrawal. Journal of Clinical Anesthesia 7:8, pages 652-656.
Crossref
Crossref
M. Daras, L. Kakkouras, A. J. Tuchman & B. S. Koppel. (2009) Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?. Acta Neurologica Scandinavica 92:2, pages 161-165.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 1995. Drug and Alcohol Abuse. Drug and Alcohol Abuse
118
144
.
Clifton W Callaway & Richard F Clark. (1994) Hyperthermia in Psychostimulant Overdose. Annals of Emergency Medicine 24:1, pages 68-76.
Crossref
Crossref
Juan R. Sanchez-Ramos. (1993) Psychostimulants. Neurologic Clinics 11:3, pages 535-554.
Crossref
Crossref
Terry D. Heiman-Patterson. (1993) Neuroleptic malignant syndrome and malignant hyperthermia: Important issues for the medical consultant. Medical Clinics of North America 77:2, pages 477-492.
Crossref
Crossref
Neal L. Benowitz. (2009) Clinical Pharmacology and Toxicology of Cocaine. Pharmacology & Toxicology 72:1, pages 3-12.
Crossref
Crossref
Robert L. Rodnitzky & Daniel L. Keyser. (1992) Neurologic Complications of Drugs. Psychiatric Clinics of North America 15:2, pages 491-510.
Crossref
Crossref
MaCaulay J. Akpaffiong & Pedro Ruiz. (1991) Neuroleptic malignant syndrome: A complication of neuroleptics and cocaine abuse. Psychiatric Quarterly 62:4, pages 299-309.
Crossref
Crossref
Robert D Welch, Keir Todd & Gary S Krause. (1991) Incidence of cocaine-Associated rhabdomyolysis. Annals of Emergency Medicine 20:2, pages 154-157.
Crossref
Crossref
Linda S. Wong & Bruce K. Alexander. (1991) “Cocaine-Related” Deaths: Media Coverage in the War on Drugs. Journal of Drug Issues 21:1, pages 105-119.
Crossref
Crossref
Thomas W. Seale. 1991. The Genetic Basis of Alcohol and Drug Actions. The Genetic Basis of Alcohol and Drug Actions
279
321
.
A. M. P. Kellam. (2018) The (Frequently) Neuroleptic (Potentially) Malignant Syndrome. British Journal of Psychiatry 157:2, pages 169-173.
Crossref
Crossref
Alan I. Green & Carl Salzman. 1990.
28
34
.
Steven E. Krug. (1989) Cocaine abuse: Historical, epidemiological, and clinical perspectives for pediatricians. Current Problems in Pediatrics 19:9, pages 451-487.
Crossref
Crossref
Marc A. SchuckitMarc A. Schuckit. 1989. Drug and Alcohol Abuse. Drug and Alcohol Abuse
96
117
.